Research
Hormonal
Tirzepatide has recently demonstrated that body weight reduction exceeding 20% in people with obesity is feasible.
Tirzepatide may be considered for patients seeking substantial weight loss.
StrongSupportsmedium confidence
Tirzepatide...has recently demonstrated that body weight reduction exceeding 20% in people with obesity and coupled with improved cardiometabolic measures is feasible.
Why this rating
The claim is based on recent clinical findings regarding a specific medication.
Source
New insights into the treatment of obesity
Matthias Blüher et al. · Diabetes Obesity and Metabolism · 2023
reviewCited 142×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →